ArticleFrontiers in oncology2022

A new core-shell-type nanoparticle loaded with paclitaxel/norcantharidin and modified with APRPG enhances anti-tumor effects in hepatocellular carcinoma.

Ming-Hua Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.